BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 6228281)

  • 1. High renal activity on bone scintigrams. A sign of hypercalcaemia?
    Buxton-Thomas MS; Wraight EP
    Br J Radiol; 1983 Dec; 56(672):911-4. PubMed ID: 6228281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The kidneys and urinary tracts, as demonstrated by skeletal scintigraphy with 99m technetium-methyl diphosphonate (author's transl)].
    Crone-Münzebrock W
    Rofo; 1980 Jul; 133(1):75-8. PubMed ID: 6451535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pitfalls of absent or faint kidney sign or bone scan.
    Constable AR; Cranage RW
    J Nucl Med; 1981 Jul; 22(7):658. PubMed ID: 6454765
    [No Abstract]   [Full Text] [Related]  

  • 4. Increased skeletal:renal uptake ratio: etiology and characteristics.
    Cheng TH; Holman BL
    Radiology; 1980 Aug; 136(2):455-9. PubMed ID: 6447313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of intense renal parenchymal activity ("hot kidneys") on bone scintigraphy.
    Bernard MS; Hayward M; Hayward C; Mundy L
    Clin Nucl Med; 1990 Apr; 15(4):254-6. PubMed ID: 2340659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased technetium-99 m hydroxy diphosphonate soft tissue uptake on bone scintigraphy in chronic kidney disease patients with secondary hyperparathyroidism: correlation with hyperphosphataemia.
    Enevoldsen LH; Heaf J; Højgaard L; Zerahn B; Hasbak P
    Clin Physiol Funct Imaging; 2017 Mar; 37(2):131-136. PubMed ID: 26148143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diffusely increased Tc-99m-MDP uptake in both kidneys.
    Koizumi K; Tonami N; Hisada K
    Clin Nucl Med; 1981 Aug; 6(8):362-5. PubMed ID: 6455233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of bone imaging with Tc-99m DPD and Tc-99m MDP: concise communication.
    Buell U; Kleinhans E; Zorn-Bopp E; Reuschel W; Muenzing W; Moser EA; Seiderer M
    J Nucl Med; 1982 Mar; 23(3):214-7. PubMed ID: 6460854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myocardial uptake of a bone tracer associated with hypercalcemia.
    Atkins HL; Oster ZH
    Clin Nucl Med; 1984 Nov; 9(11):613-5. PubMed ID: 6509834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amphotericin B therapy: a cause of increased renal uptake of Tc-99m MDP.
    Trackler RT; Chinn RY
    Clin Nucl Med; 1982 Jun; 7(6):293. PubMed ID: 6211323
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of renal-skeleton ratio of technetium-99m phosphonate in multiple myeloma.
    Dey HM; Karimeddini MK; Spencer RP; Sziklas JJ
    J Nucl Med; 1985 Nov; 26(11):1270-4. PubMed ID: 4056922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Focal lung uptake of technetium 99m methylene diphosphonate associated with pulmonary emboli and hypercalcaemia.
    Wraight EP
    Br J Radiol; 1983 May; 56(665):345-7. PubMed ID: 6221773
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of prostaglandin on experimental bone malignancy and on scintigrams of bone and marrow.
    Otsuka N; Ito Y; Nagai K; Terashima H; Yanagimoto S; Muranaka A
    J Nucl Med; 1981 May; 22(5):433-40. PubMed ID: 6452515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Technetium - 99M methylene-diphosphonate bone scan: mechanisms and clinical applications.
    Tan KF; Chang CH
    Singapore Med J; 1982 Apr; 23(2):61-72. PubMed ID: 6215712
    [No Abstract]   [Full Text] [Related]  

  • 15. A clinical comparison of MDP and DMAD.
    Rosenthall L; Stern J; Arzoumanian A
    Clin Nucl Med; 1982 Sep; 7(9):403-6. PubMed ID: 6214358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Technetium-99m-methylene disphosphonate (MDP) bone scan hypercalcemia.
    Basoglu T; Canbaz F; Bernay I
    J Nucl Med; 1998 Dec; 39(12):2034, 5A. PubMed ID: 9867137
    [No Abstract]   [Full Text] [Related]  

  • 17. Recognition of the superscan in prostatic bone scintigraphy.
    Constable AR; Cranage RW
    Br J Radiol; 1981 Feb; 54(638):122-5. PubMed ID: 7459549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bone scintigraphy in patients with malignancy associated with hypercalcemia].
    Fukunaga M; Otsuka N; Sone T; Nagai K; Ono S; Muranaka A; Furukawa T; Yanagimoto S; Tomomitsu T; Morita R
    Kaku Igaku; 1986 May; 23(5):495-8. PubMed ID: 3735789
    [No Abstract]   [Full Text] [Related]  

  • 19. [Investigation of 99mTc-methylene diphosphonate scintigraphy of patients with lung cancer].
    Abe M; Ohde R; Ogata T; Kawaguchi S; Kikuchi K; Kawai T; Matsuzawa K; Takanoshi H
    Rinsho Hoshasen; 1982 Jun; 27(6):621-5. PubMed ID: 6292553
    [No Abstract]   [Full Text] [Related]  

  • 20. Relative lesion detection ability of Tc-99m HMDP and Tc-99m MDP: concise communication.
    Van Duzee BF; Schaefer JA; Ball JD; Chilton HM; Cowan RJ; Kuni C; Trow R; Watson NE
    J Nucl Med; 1984 Feb; 25(2):166-9. PubMed ID: 6233404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.